Clinical significance of SQSTM1/P62 and nuclear factor-κB expression in pancreatic carcinoma

Table 3 Relationships between the positive expression of P62 and clinicopathological features in pancreatic carcinoma (n = 37)

Clinicopathologic feature	n	P62		P value1
		+++	++
Gender	37	22	15	0.093
Male	21	10	11
Female	16	12	4
Age (yr)				0.036
< 60	22	10	12
≥ 60	15	12	3
Pathology type				0.310
Duct adenocarcinoma	26	13	13
Adenocarcinoma	9	7	2
Squamous cell carcinoma	1	1	0
Acinic cell carcinoma	1	1	0
T stage				0.967
T0	0	0	0
T1	0	0	0
T2	10	6	4
T3	27	16	11
T4	0	0	0
N stage				0.791
N0	34	20	14
N1	3	2	1
N2	0	0	0
N3	0	0	0
M stage				0.220
M0	36	22	14
M1	1	0	1
TNM stage				0.469
I	10	6	4
II	26	16	10
III	0	0	0
IV	1	0	1

¹Pearson χ². TNM: Tumor-node-metastasis.